The growing demand for GLP-1 drugs has raised concerns about potential misuse and the lack of evidence guiding their use ...

Patients have been left feeling suicidal after feeling like their doctor was saying their symptoms were 'all in their head' – ...

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...

Rare variants in a gene involved in early development have been linked to a range of dental differences in people, including ...

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more ...

Researchers analyzed reports from 9,150 US adults and found that current or previous GLP-1/GIP use rose from 8.2% to 12% ...

Large language models (LLMs), such as ChatGPT and Claude, are increasingly being used to provide health information to the ...

Researchers compared semaglutide-treated male and female rats with pair-fed animals receiving the same amount and type of ...

Researchers analyzed beverage intake and oral microbiome data from 5,598 adults across three US cohorts and found that ...

Researchers analyzed vaginal microbiota, metabolites, and psychological questionnaire scores in 105 young Italian women and ...

New research led by the University of Michigan contains valuable insights for public health officials and communities in ...

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.